Hereditary Angioedema Therapeutic Market Projected to Reach US$ 16.54 Billion by 2030, Growing at a CAGR of 16.79% Summary: The Hereditary Angioedema Therapeutic Market is on a rapid growth trajectory, with a projected market value of US$ 16.54 billion by 2030. This robust growth, anticipated at a compound annual growth rate (CAGR) of 16.79%, underscores the increasing demand for...